Caris Life Sciences, Inc. (CAI)
30.56
-1.20
(-3.78%)
USD |
NASDAQ |
Oct 16, 16:00
30.55
-0.01
(-0.03%)
After-Hours: 20:00
Caris Life Sciences Research and Development Expense (Annual) : 101.58M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 101.58M |
| December 31, 2024 | 113.92M |
| Date | Value |
|---|---|
| December 31, 2023 | 116.88M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| CareDx, Inc. | 71.43M |
| Natera, Inc. | 624.11M |
| Myriad Genetics, Inc. | 106.80M |
| BioRestorative Therapies, Inc. | 10.09M |
| Exagen, Inc. | 6.254M |